Activity of albumin conjugates of 5-fluorodeoxyuridine and cytosine arabinoside on poxviruses as a lysosomotropic approach to antiviral chemotherapy.
D000818:Animals; D002460:Cell Line; D003561:Cytarabine / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D004481:Ectromelia virus / Q000187:drug effects*; D004482:Ectromelia, Infectious / Q000188:drug therapy; D005467:Floxuridine / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D008099:Liver / Q000382:microbiology; D008247:Lysosomes / Q000378:metabolism; D008264:Macrophages / Q000382:microbiology; D051379:Mice; D014677:Pharmaceutical Vehicles; D011213:Poxviridae Infections / Q000662:veterinary; D012376:Rodent Diseases / Q000188:drug therapy; D012709:Serum Albumin / Q000008:administration & dosage*; D014616:Vaccinia virus / Q000187:drug effects*; D014779:Virus Replication / Q000187:drug effects*
D014677:Pharmaceutical Vehicles; D012709:Serum Albumin; D005467:Floxuridine; D003561:Cytarabine